Project Details
Description
Myeloma occurs when abnormal plasma cells multiply at an increased rate in bone marrow, affecting normal function. As the median survival for myeloma is only 4-5 years, evidence based research is needed to improve patient outcomes. The range of treatment options has changed dramatically over the last decade resulting in improved survival for patients with myeloma.
| Status | Active |
|---|---|
| Effective start/end date | 4/1/92 → 12/31/29 |
Funding
- Social Sciences and Humanities Research Council of Canada: US$14,445.00
ASJC Scopus Subject Areas
- Medicine(all)
- Physical and Theoretical Chemistry
- Law
- Cancer Research
- Oncology